Evidence map›Paper›PMID 29925837›Full record

ArticleCell death & disease2018

SERPINB2 is a novel indicator of stem cell toxicity.

Na-Hee Lee, Ara Cho, Se-Ra Park, Jin Woo Lee, Park Sung Taek, Chan Hum Park, Yoon-Hyeong Choi, Soyi Lim, Min-Kwan Baek, Dong Young Kim and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. SerpinB2 Regulates Immune Response in Kidney Injury and Aging.Journal of the American Society of Nephrology : JASN · 2020
    Article
  19. Article
  20. An Endogenous Anti-aging Factor, Sonic Hedgehog, Suppresses Endometrial Stem Cell Aging through SERPINB2.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Na-Hee LeeDepartment of Health Sciences and Technology, GAIHST, Gachon University, Incheon, 21999, Republic of Korea.
Ara ChoDepartment of Health Sciences and Technology, GAIHST, Gachon University, Incheon, 21999, Republic of Korea.
Se-Ra ParkDepartment of Health Sciences and Technology, GAIHST, Gachon University, Incheon, 21999, Republic of Korea.
Jin Woo LeeDepartment of Health Sciences and Technology, GAIHST, Gachon University, Incheon, 21999, Republic of Korea.
Park Sung TaekDepartment of Obstetrics and Gynecology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
Chan Hum ParkDepartment of Otolaryngology-Head and Neck Surgery, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Republic of Korea.
Yoon-Hyeong ChoiDepartment of Preventive Medicine, Gachon University Graduate School of Medicine, Incheon, Republic of Korea.
Soyi LimDepartment of Obstetrics and Gynecology, Gachon University Gil Medical Center, Incheon, Republic of Korea.
Min-Kwan BaekDepartment of Otolaryngology-Head and Neck Surgery, Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
Dong Young KimDepartment of Otolaryngology-Head and Neck Surgery, Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
Mirim JinCollege of Medicine, Gachon University, Incheon, Republic of Korea.
Hwa-Yong LeeDepartment of Biomedical Science, Jungwon University, 85 Goesan-eup,Munmu-ro, Goesan-gun, Chungcheongbuk-do, 367-700, Republic of Korea. hylee@jwu.ac.kr.
In-Sun HongDepartment of Health Sciences and Technology, GAIHST, Gachon University, Incheon, 21999, Republic of Korea. hongstem@gachon.ac.kr.
Gachon University · KRGachon University Gil Medical Center · KRHallym University Chuncheon Sacred Heart Hospital · KRHallym University Kangnam Sacred Heart Hospital · KRJungwon University · KR

Funding

National Research Foundation of Korea (NRF) 2016R1C1B2009351National Research Foundation of Korea (NRF) NRF-2018R1C1B6003442
6 · The paper itself

Abstract

The toxicological evaluation of potential drug candidates is very important in the preclinical phase of drug development. Toxic materials may cause serious decline in stem cell function and loss of stemness. Indeed, we found that toxic exposure more profoundly suppressed the growth of stem cells than terminally differentiated fibroblasts. Importantly, toxic exposure suppressed stem cell migration and multi-lineage differentiation potential in vitro and in vivo. Moreover, early-response genes involved in stem cell properties such as self-renewal and differentiation capabilities can be used as specific markers to predict toxicity. In the present study, we also identified a labile toxic response gene, SERPINB2, which is significantly increased in response to various toxic agents in human stem cells in vitro and in vivo. Consistently, self-renewal, migration, and multi-lineage differentiation potential were markedly decreased following SERPINB2 overexpression. To the best of our knowledge, this is the first study to focus on the functions of SERPINB2 on the regenerative potential of stem cells in response to various existing chemicals, and the findings will facilitate the development of promising toxicity test platforms for newly developed chemicals.

Indexed as

AnimalsCell DifferentiationCell ProliferationCell Self RenewalCell SurvivalDioxinsHumansMesenchymal Stem CellsMiceSerpinsDioxinsSerpins

Identifiers

PMID29925837
PMCPMC6010432
OpenAlexW2809034747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.